Ted Buchan & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.69M | Buy |
92,754
+7,235
| +8% | +$600K | 3.06% | 10 |
|
|
2025
Q1 | $6.94M | Buy |
85,519
+288
| +0.3% | +$23.4K | 3.28% | 11 |
|
|
2024
Q4 | $7.68M | Sell |
85,231
-4,977
| -6% | -$448K | 3.62% | 10 |
|
|
2024
Q3 | $8.91M | Sell |
90,208
-5,322
| -6% | -$526K | 4.23% | 8 |
|
|
2024
Q2 | $8.86M | Buy |
95,530
+1,348
| +1% | +$125K | 4.75% | 5 |
|
|
2024
Q1 | $8.94M | Sell |
94,182
-305
| -0.3% | -$28.9K | 5.49% | 5 |
|
|
2023
Q4 | $8.44M | Buy |
94,487
+477
| +0.5% | +$42.6K | 6.14% | 4 |
|
|
2023
Q3 | $6.86M | Buy |
94,010
+912
| +1% | +$66.6K | 5.52% | 6 |
|
|
2023
Q2 | $7.75M | Buy |
93,098
+4,677
| +5% | +$389K | 5.96% | 5 |
|
|
2023
Q1 | $6.74M | Buy |
88,421
+73,229
| +482% | +$5.58M | 5.63% | 6 |
|
|
2022
Q4 | $1.26M | Buy |
+15,192
| New | +$1.26M | 1.17% | 17 |
|